Understanding malignant hyperthermia: each move forward opens our eyes to the distance left to travel.

@article{Dirksen2019UnderstandingMH,
  title={Understanding malignant hyperthermia: each move forward opens our eyes to the distance left to travel.},
  author={R. Dirksen and P. Allen and J. R. L{\'o}pez},
  journal={British journal of anaesthesia},
  year={2019},
  volume={122 1},
  pages={
          8-9
        }
}
Understanding malignant hyperthermia: each move forward opens our eyes to the distance left to travel R. T. Dirksen, P. D. Allen and J. R. Lopez University of Rochester Medical Center, Department of Pharmacology and Physiology, Rochester, NY, USA, Leeds Institute of Biomedical & Clinical Sciences, School of Medicine, University of Leeds, St James’s University Hospital, Leeds, UK and Mount Sinai Medical Center, Miami Beach, FL, USA 

References

SHOWING 1-10 OF 11 REFERENCES
Voltage modulates halothane-triggered Ca2+ release in malignant hyperthermia-susceptible muscle
  • 8
  • PDF
Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study
  • 43
  • PDF
Ryanodine receptor type 1 gene mutations found in the Canadian malignant hyperthermia population
  • 35
  • PDF
Mice expressing T4826I‐RYR1 are viable but exhibit sex‐ and genotype‐dependent susceptibility to malignant hyperthermia and muscle damage
  • 50
...
1
2
...